Standout Papers

A potent specific pure antiestrogen with clinical potential. 1991 2026 2002 2014 950
  1. A potent specific pure antiestrogen with clinical potential. (1991)
    A. E. Wakeling, Michael Dukes et al. PubMed
  2. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. (2002)
    Stephen R. Wedge, Donald Ogilvie et al. PubMed

Immediate Impact

3 by Nobel laureates 39 from Science/Nature 88 standout
Sub-graph 1 of 19

Citing Papers

Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
5 intermediate papers

Works of Michael Dukes being referenced

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
2002 Standout
Novel 4-Anilinoquinazolines with C-7 Basic Side Chains:  Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors
2002
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael Dukes 984 1068 127 896 14 2.5k
Alan E. Wakeling 1581 1463 174 1224 42 3.1k
Antonio Bilancio 1101 2414 93 1146 42 4.6k
Jean Bowler 1514 801 41 525 21 2.1k
Yoko Omoto 1163 1110 64 856 48 2.5k
Joseph Dinchuk 1643 1215 108 679 20 4.7k
Sophie Dauvois 2216 1774 46 726 26 3.0k
Mark Clemons 804 1077 111 2093 29 3.3k
Suzanne E. Wardell 1022 1610 43 910 50 3.3k
R A McClelland 1041 972 210 1248 45 2.4k
Erika Krasnickas Keeton 920 1592 27 585 18 2.3k

All Works

Loading papers...

Rankless by CCL
2026